IL314684A - Methods for losing weight and preserving skeletal muscle mass - Google Patents

Methods for losing weight and preserving skeletal muscle mass

Info

Publication number
IL314684A
IL314684A IL314684A IL31468424A IL314684A IL 314684 A IL314684 A IL 314684A IL 314684 A IL314684 A IL 314684A IL 31468424 A IL31468424 A IL 31468424A IL 314684 A IL314684 A IL 314684A
Authority
IL
Israel
Prior art keywords
methods
weight loss
skeletal muscle
muscle mass
preserving
Prior art date
Application number
IL314684A
Other languages
English (en)
Hebrew (he)
Inventor
Shaharyar Khan
Diane Jorkasky
Francisco Portell
Original Assignee
Rivus Pharmaceuticals Inc
Shaharyar Khan
Diane Jorkasky
Francisco Portell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rivus Pharmaceuticals Inc, Shaharyar Khan, Diane Jorkasky, Francisco Portell filed Critical Rivus Pharmaceuticals Inc
Publication of IL314684A publication Critical patent/IL314684A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41681,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL314684A 2022-02-07 2023-02-06 Methods for losing weight and preserving skeletal muscle mass IL314684A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263307506P 2022-02-07 2022-02-07
US202263382456P 2022-11-04 2022-11-04
PCT/US2023/062077 WO2023150767A1 (en) 2022-02-07 2023-02-06 Methods of weight loss and preserving skeletal muscle mass

Publications (1)

Publication Number Publication Date
IL314684A true IL314684A (en) 2024-10-01

Family

ID=85556813

Family Applications (1)

Application Number Title Priority Date Filing Date
IL314684A IL314684A (en) 2022-02-07 2023-02-06 Methods for losing weight and preserving skeletal muscle mass

Country Status (12)

Country Link
US (1) US20250134864A1 (https=)
EP (1) EP4475841A1 (https=)
JP (1) JP2025505187A (https=)
KR (1) KR20240146052A (https=)
AU (1) AU2023216366A1 (https=)
CA (1) CA3243640A1 (https=)
CL (1) CL2024002341A1 (https=)
GE (1) GEAP202416578A (https=)
IL (1) IL314684A (https=)
JO (1) JOP20240177A1 (https=)
MX (1) MX2024009646A (https=)
WO (1) WO2023150767A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025199516A1 (en) * 2024-03-22 2025-09-25 Board Of Regents, The University Of Texas System Compositions and methods for preserving or increasing lean muscle mass

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3565806T (pt) 2017-01-06 2022-05-19 Rivus Pharmaceuticals Inc Novos derivados de fenilo

Also Published As

Publication number Publication date
US20250134864A1 (en) 2025-05-01
CA3243640A1 (en) 2023-08-10
JOP20240177A1 (ar) 2024-08-04
GEAP202416578A (en) 2024-11-11
WO2023150767A1 (en) 2023-08-10
EP4475841A1 (en) 2024-12-18
CL2024002341A1 (es) 2025-01-17
KR20240146052A (ko) 2024-10-07
MX2024009646A (es) 2024-11-08
AU2023216366A1 (en) 2024-08-15
JP2025505187A (ja) 2025-02-21

Similar Documents

Publication Publication Date Title
EP4210713A4 (en) SKELETAL MUSCLE RELEASE PLATFORMS AND METHODS OF USE
ES3062897T3 (en) Compositions and methods of treating muscle dystrophy
SG11202107701VA (en) Isolation and cultivation of muscle and fat cells from crustaceans
IL314684A (en) Methods for losing weight and preserving skeletal muscle mass
GB2581744B (en) Weight rack system and methods of making and using same
IL308041A (en) Collagen compositions and methods of using them
GB2622995B (en) CAS13-based compositions and methods of use thereof
SG11202001965PA (en) Protein-dense nutritional compositions for use in treating and/or preventing a condition linked to loss of muscle mass and/or strength
HK40119961A (en) Methods of weight loss and preserving skeletal muscle mass
IL315862A (en) Angiotensinogen modulators and methods of using them
GB202207983D0 (en) Methods of preparing functional surafces and surfaces prepared thereby
GB2599284B (en) Edible paste and composition and method of preparation
CA3298873A1 (en) Methods and compositions for maintaining skeletal muscle mobility and/or mass, and/or for recovery of skeletal muscle strength
HK40096248A (en) Skeletal muscle delivery platforms and methods of use
CA234589S (en) Adjustable weight dumbbell
HK40111238A (en) Adeno-associated viral vector compositions and methods of promoting muscle regeneration
IL326294A (en) Epilepsy compositions and methods of use
GB202313643D0 (en) Serping1-sarna compositions and methods of use
GB202310868D0 (en) compositions and methods of use
IL325884A (en) Compositions comprising GAL475 and methods of using them
NO20191178A1 (en) Exercise rucksack and method of manufacture
GB2591342B (en) Sports training aid and method of use
CA3303916A1 (en) Methods and compositions for reducing muscle loss and/or inhibiting sarcopenia associated with weight loss
GB202416890D0 (en) Packaging and method of use and/or construction thereof
GB202311284D0 (en) Cells and methods of preparation